Enorama Pharma AB (publ) (STO:ERMA)

Enorama Pharma AB Statistics

Total Valuation

STO:ERMA has a market cap or net worth of SEK 117.48 million. The enterprise value is 110.91 million.

Market Cap	117.48M
Enterprise Value	110.91M

Important Dates

The next estimated earnings date is Tuesday, February 17, 2026.

Earnings Date	Feb 17, 2026
Ex-Dividend Date	n/a

Share Statistics

STO:ERMA has 74.59 million shares outstanding. The number of shares has increased by 37.91% in one year.

Current Share Class	74.59M
Shares Outstanding	74.59M
Shares Change (YoY)	+37.91%
Shares Change (QoQ)	+12.52%
Owned by Insiders (%)	20.38%
Owned by Institutions (%)	1.69%
Float	15.81M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	32.36
PB Ratio	-25.27
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-1.45
EV / Sales	30.55
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.71

Current Ratio	0.71
Quick Ratio	0.46
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-7.41

Financial Efficiency

Return on equity (ROE) is -526.84% and return on invested capital (ROIC) is -301.02%.

Return on Equity (ROE)	-526.84%
Return on Assets (ROA)	-163.56%
Return on Invested Capital (ROIC)	-301.02%
Return on Capital Employed (ROCE)	1,523.30%
Revenue Per Employee	726,000
Profits Per Employee	-15.31M
Employee Count	5
Asset Turnover	0.13
Inventory Turnover	2.71

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -55.88% in the last 52 weeks. The beta is 1.67, so STO:ERMA's price volatility has been higher than the market average.

Beta (5Y)	1.67
52-Week Price Change	-55.88%
50-Day Moving Average	2.39
200-Day Moving Average	2.53
Relative Strength Index (RSI)	31.02
Average Volume (20 Days)	12,011

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, STO:ERMA had revenue of SEK 3.63 million and -76.57 million in losses. Loss per share was -1.16.

Revenue	3.63M
Gross Profit	-12.84M
Operating Income	-70.80M
Pretax Income	-76.57M
Net Income	-76.57M
EBITDA	-72.51M
EBIT	-70.80M
Loss Per Share	-1.16

Balance Sheet

The company has 6.56 million in cash and n/a in debt, with a net cash position of 6.56 million or 0.09 per share.

Cash & Cash Equivalents	6.56M
Total Debt	n/a
Net Cash	6.56M
Net Cash Per Share	0.09
Equity (Book Value)	-4.65M
Book Value Per Share	-0.06
Working Capital	-5.00M

Cash Flow

Operating Cash Flow	-47.77M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	-1,950.50%
Pretax Margin	-2,109.39%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

STO:ERMA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-37.91%
Shareholder Yield	-37.91%
Earnings Yield	-65.18%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

STO:ERMA has an Altman Z-Score of -44.39 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-44.39
Piotroski F-Score	1